The short answer
Advanced melanoma runs on two tracks, immunotherapy and targeted therapy, and one test decides whether the second is open. NCI groups unresectable stage III, stage IV and recurrent disease together.
NCI names several immunotherapy options, from current checkpoint drugs to older agents such as interleukin-2 that are now used rarely; the list is not a running order.
The targeted drugs are dabrafenib, trametinib, vemurafenib, cobimetinib, encorafenib and binimetinib, given alone or in pairs.
Only tumors with a BRAF change can use the targeted track; a negative result leaves the immunotherapy track, not a dead end.
NCI uses lactate dehydrogenase as a prognostic marker in advanced melanoma, so ask for the level and the trend.
Choose how you want to understand this
The full explanation.
Two treatment tracks, not one
Advanced melanoma splits into immunotherapy and targeted therapy.
NCI groups three situations together. They are stage III melanoma that cannot be removed, stage IV, and recurrent melanoma. For all three it lists immunotherapy, naming pembrolizumab, nivolumab, ipilimumab, interleukin-2, atezolizumab, and nivolumab with relatlimab. Take that as a catalogue, not a running order. Interleukin-2 is from an earlier era and is now used rarely, in a few centres. What your team proposes rests on your BRAF result, what you have had before, how fast things are moving, and your other health.
The targeted list is dabrafenib, trametinib, vemurafenib, cobimetinib, encorafenib and binimetinib. These are given alone or in pairs.
Which track you can use starts with one test.
The BRAF test opens or closes the second track
Only tumours with the right kind of BRAF change can use the targeted drugs. That usually means a V600 change. The drugs are given in pairs, with a MEK inhibitor. Ask whether BRAF testing was done and which exact variant it found. Then ask whether the drugs are approved for that variant. A positive result does not mean targeted therapy goes first. That depends on how fast things are moving, your symptoms, and what you have had before.
A negative result is not a dead end. It simply means the immunotherapy track is the one available.
LDH, and why they keep drawing it
Lactate dehydrogenase is a blood test. NCI's melanoma summaries use it as a prognostic marker in advanced disease.
Ask what your level is and how it is being tracked over time.
Melanoma and the brain
Melanoma reaches the brain more readily than most cancers, so this comes up early.
NCI describes a trial of nivolumab plus ipilimumab in people with brain metastases. They had no nerve symptoms and needed no urgent treatment. Some had already had focused radiation or surgery for up to three brain spots.
So both radiation and drug treatment have a place. Ask which one your team would do first, and why.
Questions for the melanoma team
- Has my tumor been tested for a BRAF change?
- If it is BRAF positive, would you start immunotherapy or targeted therapy, and why?
- What is my LDH, and what does the trend mean?
- Have I had brain imaging, even without symptoms?
- If there are brain spots, does radiation come first or does the drug?
- What is the trade-off between one immunotherapy drug and two?
- Which immune side effects mean I should call the same day?
Immune side effects are the price of the good results
Checkpoint drugs can inflame almost any organ. The usual ones are the bowel, thyroid, liver, lungs, skin and pituitary gland.
Ask for the list in writing and the 24-hour number on the same page, and carry your immunotherapy card. Reporting early matters because the team needs to grade the problem and rule out infection before treating it.
When melanoma is limited to a limb
NCI's summaries list isolated limb infusion, and list isolated limb perfusion for unresectable limb melanoma as still under clinical evaluation. They also list talimogene laherparepvec, a treatment injected directly into the deposits.
If your disease is in-transit and limited to one limb, ask whether either applies.
When to get help sooner
- Call 911 or go to an emergency department if you have a seizure, sudden weakness or numbness on one side, sudden confusion, trouble speaking, or a severe headache that came on fast. Melanoma reaches the brain more often than most cancers, and NCI lists headache, seizures and dizziness as signs of spread there.
- Call 911 or go to an emergency department if you are on a checkpoint drug and chest pain starts, or you are breathless at rest. These drugs can inflame the heart muscle as well as the lungs, and that turns dangerous quickly.
- Call your care team the same day if you are on a checkpoint drug and you get diarrhea several times above your normal, belly pain, a new cough, breathlessness on exertion, yellowing of the skin or eyes, dark urine, or a temperature of 100.4°F (38°C) or higher. These can be the bowel, lung or liver inflammation these drugs cause. Ring the 24-hour oncology line rather than waiting. Say which drug you are on. The team will grade how bad it is and check for infection before they treat it.
- Call your care team within a day or two if you notice a spreading rash, unusual thirst or passing a lot of urine, ankle swelling, or tiredness and dizziness that are new and getting worse. Thyroid, pituitary, kidney and pancreas inflammation build up more slowly, but they still need treating.
Related pages
Related: Biomarker Testing, Cancer Staging, Clinical Trial vs Standard Treatment, and Palliative Care.
Where this comes from
Words to know
Tap any term to see what it means.

Common questions
What does a BRAF result change?
It opens or closes the targeted track. The BRAF inhibitors — dabrafenib, vemurafenib, encorafenib, given with a MEK partner — are for tumours carrying a particular kind of BRAF change, most often V600. The exact variant on the report matters, so ask which one was found. If BRAF is negative, immunotherapy is the track that applies. Even with a positive result, which track goes first is a judgement about pace of disease, symptoms and what you have already had.
Can I be treated if melanoma has reached my brain?
NCI describes a trial of nivolumab plus ipilimumab in people with brain metastases who had no nerve symptoms and needed no urgent treatment; some had already had focused radiation or surgery for up to three brain spots. Ask whether radiation or the drug comes first for you.
What should I have written down before immunotherapy starts?
The list of immune side effects and the after-hours number, on the same page. Diarrhea, breathlessness, yellowing skin or a fever need a call the same day, and sooner if severe. Reporting early lets the team check whether it is the drug or an infection before treating it.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-11 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
